Healthcare resource utilization and costs associated with postpartum depression among commercially insured households.

Current Medical Research and Opinion
C Neill EppersonAdi Eldar-Lissai

Abstract

To quantify the economic burden of postpartum depression (PPD) that accrues to commercially insured households in the year following childbirth. Administrative claims data from OptumHealth Care Solutions (2009-2016) were used to identify households that included women identified with PPD per the algorithm and propensity score-matched comparison households of women who were not identified with PPD or a history of depression after childbirth. Study outcomes included direct total all-cause medical and pharmaceutical costs during the first year following childbirth and number of outpatient visits at the household level stratified by household member. Households affected by PPD as identified by the algorithm (N = 7769) incurred 22% higher mean total all-cause medical and pharmaceutical spending than unaffected matched controls (N = 41,308) during the first year following childbirth ($36,049 versus $29,448, p < 0.01) and an average of 16 more outpatient visits than unaffected households (p < .01). Costs accrued by mothers comprised the largest share (>50%) of total all-cause spending. Mothers identified with PPD had significantly higher annual mean direct total all-cause medical and pharmaceutical spending than their matched controls...Continue Reading

References

Jun 16, 2004·Archives of Internal Medicine·David N JuurlinkDonald A Redelmeier
Sep 28, 2007·The American Journal of Psychiatry·Patricia M DietzMark C Hornbrook
Sep 2, 2008·Respiratory Medicine·Manabu AkazawaChristopher M Blanchette
Feb 4, 2010·Archives of Women's Mental Health·Katherine L WisnerDorothy K Y Sit
Feb 17, 2010·Journal of Women's Health·Janice H Goodman, Lynda Tyer-Viola
Sep 28, 2010·Statistical Science : a Review Journal of the Institute of Mathematical Statistics·Elizabeth A Stuart
Dec 4, 2010·Archives of Disease in Childhood·Luigi GagliardiFranca Rusconi
Jun 3, 2011·Psychiatric Services : a Journal of the American Psychiatric Association·Katy Backes KozhimannilAlyce S Adams
Jun 10, 2011·Child: Care, Health and Development·L A QuevedoR T Pinheiro
Jan 24, 2012·Journal of Occupational and Environmental Medicine·Rada K DagherDwenda K Gjerdingen
Mar 16, 2013·Journal of Women's Health·Shahed AbbasiKristen Kjerulff
Mar 6, 2015·The Journal of Clinical Psychiatry·Paul E GreenbergRonald C Kessler
Apr 10, 2015·Archives of Women's Mental Health·Birgitta KerstisAlkistis Skalkidou
Apr 14, 2015·The Journal of Pediatrics·Judith van der WaerdenUNKNOWN EDEN Mother–Child Cohort Study Group
May 2, 2015·Obstetrics and Gynecology·UNKNOWN Committee on Obstetric Practice
Dec 24, 2015·Nursing & Health Sciences·Reema R SafadiMuayyad M Ahmad
Oct 26, 2016·The Journal of Clinical Psychiatry·Elizabeth Q CoxBradley N Gaynes
Feb 14, 2017·Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN·Susan KendigLauren A Lemieux
Feb 17, 2017·MMWR. Morbidity and Mortality Weekly Report·Jean Y KoSherry L Farr
Oct 14, 2018·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Laura J Sherman, Mir M Ali
Nov 24, 2018·Current Medical Research and Opinion·Tiffany A Moore SimasAdi Eldar-Lissai
Apr 17, 2020·American Journal of Public Health·Dara Lee LucaKara Zivin
May 15, 2020·MMWR. Morbidity and Mortality Weekly Report·Brenda L BaumanWanda D Barfield

❮ Previous
Next ❯

Citations

Jul 13, 2021·Journal of Midwifery & Women's Health·Yeon Bai, Jennifer Kuscin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.